Understanding fertility preservation in transgender patients
The Determinants of Fertility Preservation in TRANSgender Patients (FP-TRANS).
Central Hospital, Nancy, France · NCT06074796
This study looks at what factors influence transgender patients' decisions about preserving their fertility to better support those considering parenthood.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 230 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Central Hospital, Nancy, France (other) |
| Locations | 1 site (Nancy) |
| Trial ID | NCT06074796 on ClinicalTrials.gov |
What this trial studies
This observational study aims to analyze the factors influencing fertility preservation decisions among transgender patients at the University Regional Hospital Center in Nancy. By comparing profiles of patients who choose to undergo fertility preservation with those who do not, the study seeks to identify significant determinants affecting these choices. The research is retrospective and utilizes existing data collected during routine consultations related to the transition process. The goal is to enhance support for transgender patients considering parenthood by establishing a comprehensive database of their experiences and preferences.
Who should consider this trial
Good fit: Ideal candidates for this study are transgender patients who have consulted the Assisted Reproductive Technology center in Nancy between January 2020 and June 2023.
Not a fit: Patients who are minors or under guardianship will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights that improve fertility preservation options and support for transgender patients.
How similar studies have performed: While this study addresses a specific population, similar studies have shown success in understanding fertility preservation in other demographics, making this approach both relevant and necessary.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Transgender patients who consulted the Assisted Reproductive Technology centre of the Nancy Regional University Hospital, between 1st January 2020 and 30th June 2023. The consultations occurred for the start of transition care, for follow-up or for a parenting project for transgender patients. Exclusion Criteria: * minors * patients under guardianship or under tutelage
Where this trial is running
Nancy
- Centre AMP Maternité Régionale de Nancy — Nancy, France (RECRUITING)
Study contacts
- Principal investigator: Mikael AGOPIANTZ, PHD MCU — CentralHNF Nancy Regional University Hospital
- Study coordinator: Mikael Agopiantz Agopiantz, PHD
- Email: mikael.agopiantz@gmail.com
- Phone: 0033671038224
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Fertility Preservation, Transgender, Transgenderism, transgender, fertility preservation, parenthood, social determinants